|
In intensive care units, up to 30% of A. baumannii clinical isolates are resistant to at least three classes of antibiotics, often including fluoroquinolones and carbapenems.
 Now Mark Adams of Case Western Reserve University et al. show in this pathogen that multidrug resistance (MDR) is a diverse phenomenon. "A resistance island (RI) with several resistance genes is present in at least someMDR isolates, but there are additional resistance genes located outside the RI, so the RI is not the whole story," says Adams. "For example, there are five beta-lactamase genes in oneMDR strain that we sequenced, and only one is located in the RI. Extensive selective pressure seems to have resulted in a diverse gene set for inactivating beta-lactam drugs. We also found 475 genes that are shared among six clinical isolates, but are absent from a related, nonpathogenic Acinetobacter species, including a significant fraction of the transcription factors and transporters in A. baumannii." Studying these, he says, could help define what makes this bug a pathogen.
(M. D. Adams, G. C. Nickel, S. Bajaksouzian, H. Lavender, A. R. Murthy, M. R. Jacobs, and R. A. Bonomo. 2009. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 53:3628-3634.)
|
Journal Highlights 
Facebook
del.icio.us
Digg
Furl 
Yahoo!My Web
StumbleUpon
Google
Technorati 
reddit
Twitter
